BetterLife Pharma Inc. (BETRF)
OTCMKTS · Delayed Price · Currency is USD
0.0649
-0.0021 (-3.13%)
Jun 5, 2025, 3:27 PM EDT

BetterLife Pharma Cash Flow Statement

Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Jan '25 Jan '24 Jan '23 Jan '22 Jan '21 2016 - 2020
Net Income
-3.62-2.89-9.02-12.16-36.35
Upgrade
Depreciation & Amortization
--0.020.020.34
Upgrade
Loss (Gain) From Sale of Assets
-----0.8
Upgrade
Asset Writedown & Restructuring Costs
----12.12
Upgrade
Stock-Based Compensation
2.050.53.941.352.18
Upgrade
Other Operating Activities
-1.2-0.410.120.9116.9
Upgrade
Change in Accounts Receivable
0.03-0.020.310.18-0.35
Upgrade
Change in Accounts Payable
0.11-0.72.21-1.16-0.99
Upgrade
Change in Income Taxes
---0.160.17-
Upgrade
Change in Other Net Operating Assets
0.621.051.07-0.51-0.2
Upgrade
Operating Cash Flow
-2.02-2.47-1.5-11.2-7.16
Upgrade
Capital Expenditures
-----0.01
Upgrade
Cash Acquisitions
----0.03
Upgrade
Sale (Purchase) of Intangibles
-----0.09
Upgrade
Investing Cash Flow
-----0.07
Upgrade
Short-Term Debt Issued
-0.3--0.6
Upgrade
Long-Term Debt Issued
1.22--0.12-
Upgrade
Total Debt Issued
1.220.3-0.120.6
Upgrade
Short-Term Debt Repaid
----0.25-
Upgrade
Long-Term Debt Repaid
-----0.5
Upgrade
Total Debt Repaid
----0.25-0.5
Upgrade
Net Debt Issued (Repaid)
1.220.3--0.130.1
Upgrade
Issuance of Common Stock
0.752.20.7211.471.38
Upgrade
Other Financing Activities
0.02-0.61-0.12.61
Upgrade
Financing Cash Flow
1.992.51.3411.234.09
Upgrade
Foreign Exchange Rate Adjustments
0-00-0.010.02
Upgrade
Net Cash Flow
-0.030.03-0.170.02-3.13
Upgrade
Free Cash Flow
-2.02-2.47-1.5-11.2-7.18
Upgrade
Free Cash Flow Per Share
-0.02-0.02-0.02-0.15-0.27
Upgrade
Cash Interest Paid
----0.48
Upgrade
Levered Free Cash Flow
-3.01-2.122.13-6.181.51
Upgrade
Unlevered Free Cash Flow
-2.81-2.092.17-6.141.53
Upgrade
Change in Net Working Capital
-0.140.58-3.991.28-4.08
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.